HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $232,000 | +30.3% | 15,805 | +4.4% | 1.09% | -2.7% |
| Q1 2020 | $178,000 | -50.4% | 15,135 | -1.0% | 1.12% | -26.0% |
| Q4 2019 | $359,000 | -14.3% | 15,295 | -32.5% | 1.52% | -14.0% |
| Q3 2019 | $419,000 | -2.6% | 22,665 | -6.0% | 1.76% | +12.3% |
| Q2 2019 | $430,000 | -10.0% | 24,112 | +23.3% | 1.57% | -17.4% |
| Q1 2019 | $478,000 | +38.6% | 19,553 | +47.0% | 1.90% | -14.7% |
| Q4 2018 | $345,000 | +1.8% | 13,299 | +24.3% | 2.23% | +27.4% |
| Q3 2018 | $339,000 | -58.9% | 10,696 | -49.6% | 1.75% | -52.3% |
| Q2 2018 | $825,000 | -10.5% | 21,233 | -36.4% | 3.66% | -5.6% |
| Q1 2018 | $922,000 | +50.4% | 33,389 | -1.4% | 3.88% | +39.8% |
| Q4 2017 | $613,000 | +14.2% | 33,875 | +1.8% | 2.78% | +9.8% |
| Q3 2017 | $537,000 | +5.5% | 33,274 | -9.4% | 2.53% | +5.2% |
| Q2 2017 | $509,000 | – | 36,744 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |